Anagenics Ltd has released a press release.
Pause in Trading
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Anagenics
- FY24 4E Presentation
- Appendix 4E and Preliminary Final Report
- Company Update License Partnership Announcement
- Appendix 4C Cash Flow & Activities Report
- Midkine Antibody Licensing Deal
Later from Anagenics
- Suspension from Official Quotation
- Market Update
- 2024 Anagenics Annual Report
- Q1 F25 Activity Statement and Appendix 4C
- Restructuring Update & Resignation of Director
Follow Anagenics into a list and get an email when it puts out news.
Follow Anagenics